🚀 Exceptional Investment Opportunity: Next-Gen Telemedicine & Digital Health Platform (Already Branded & Market-Ready)

🚀 Exceptional Investment Opportunity: Next-Gen Telemedicine & Digital Health Platform (Already Branded & Market-Ready)

United Arab Emirates, Dubai
MP-261102Verified PropertyMedical PlatformStatus: Fully Licensed & Operational

Description

Are you ready to capitalize on the rapid transformation of the digital healthcare sector across the MENA region? We are offering an exclusive opportunity to invest in a premier, fully developed telemedicine and virtual care platform. Backed by an established identity and reputable market presence (Already Branded), the platform is primed for aggressive regional expansion and substantial commercial scale. 🎯 Investment Overview: Funding Target: AED 5,000,000. 5-Year Revenue Projection: Supported by a scalable business model and strategic expansion plans, projected annual revenues are targeted to reach AED 20M to AED 50M within the first 5 years of commercial operations. Market Opportunity: High-growth GCC HealthTech market expanding at over 12% CAGR, driven by progressive regulatory mandates and rapid digital health adoption Multi-channel revenue model: B2C tele-consultations, corporate B2B wellness programs, SaaS fees, and integrated pharmacy/lab commissions Platform Highlights: Turnkey, recognizable brand with strong market equity and zero setup lag Built-in multi-channel virtual care: high-definition video, audio, and secure async messaging Compliant unified ecosystem: EHR, e-prescriptions, connected pharmacies, and diagnostic hubs AI-ready architecture configured for clinical triage and workflow automation Confidentiality & Inquiries: An NDA is strictly required to review the pitch deck and 5-year audited financial forecast. Contact MedProp to proceed: medprop.ae

Property Overview

Location

United Arab Emirates, Dubai

Property Type

Medical Platform

Status

Fully Licensed & Operational

Asking Price

AED 12.00M

Investment Range

AED 5.00M - AED 7.00M

Listed

1 Nov 2026